不同的克隆进化和早期传播促进转移的遗传异质性在化耐药前列腺癌中
Noshad Hosseini1, Rahul Mannan2, Ryan J Rebernick3
1University of Michigan-Ann Arbor, United States.
Cancer research
|August 18, 2025
概括
致死性前列腺癌 (PCa) 在转移部位独立演变,大多数遗传变化发生在扩散后. 这强调了在癌症诊断和治疗中需要进行多地点分析的必要性.
科学领域:
- 基因组学就是基因组学.
- 进化生物学 进化生物学
- 在瘤学瘤学.
背景情况:
- 致死性前列腺癌 (PCa) 经历了进化瓶,包括转移和割抵抗.
- 了解转移部位的遗传异质性对于开发有效的治疗策略至关重要.
研究的目的:
- 研究致命前列腺癌中转移性传播和克隆进化的模式.
- 描述PCa在个体患者内多个转移部位的遗传景观.
主要方法:
- 对来自26名患者的93个瘤进行深度全外体测序.
- 遗传学重建和数学建模来分析克隆进化和突变模式.
主要成果:
- 大多数突变,拷贝数变化和克隆在最初的癌症扩散后在个体转移部位内独立出现.
- 多克隆和多种植种植有助于转移性病变的异质性.
- 单组织测序可以高估克隆性和低估突变率.
结论:
- 前列腺癌中的转移性病变是独立进化的,由多克隆播种驱动.
- 这些发现对诊断数据的解释和向治疗的开发有重大影响.
- 多部位瘤测序对于全面了解PCa演变和指导治疗决策至关重要.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancers Originate from Somatic Mutations in a Single Cell
12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


